• Explore /
  • Poster
  • / The role of Chemotherapy Response Score (CRS) in the decision making process for advanced high grade serous ovarian cancer patients undergoing neoadjuvant chemotherapy.

The role of Chemotherapy Response Score (CRS) in the decision making process for advanced high grade serous ovarian cancer patients undergoing neoadjuvant chemotherapy.

Abstract Poster

Authors

null

Claudia Marchetti

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

Claudia Marchetti , Raffaella Ergasti , Filippo Maria Capomacchia , Diana Giannarelli , Carolina Maria Sassu , Gian Franco Zannoni , Giovanni Scambia , Anna Fagotti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5591)

DOI

10.1200/JCO.2023.41.16_suppl.5591

Abstract #

5591

Poster Bd #

286

Abstract Disclosures

Similar Posters

First Author: Travis T. Sims

Poster

2021 ASCO Annual Meeting

Evaluation of a RAD51 functional assay in advanced ovarian cancer, a GINECO/GINEGEPS study.

Evaluation of a RAD51 functional assay in advanced ovarian cancer, a GINECO/GINEGEPS study.

First Author: Felix Blanc-Durand

First Author: Gwenael Ferron

First Author: Do-Youn Oh